Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Teva Pharmaceutical Industries(TEVA.US)

Event Tracking

Mar30

Teva's biosimilar approved by FDA

12:02

Mar19

Teva Exec Mark Sabag Sells Company Shares

20:02

Mar5

Highland Peak Capital LLC Reduced Holdings in Teva Pharmaceutical

12:29

Mar3

Teva Pharmaceuticals Reaches $400 Million Growth Capital Agreement with Blackstone Life Sciences

22:07

Mar2

Teva CFO Eliyahu Sharon Kalif Sells Company Stocks

21:02

Feb23

Teva's New Drug Application for Schizophrenia Accepted by FDA

13:59

Schedules & Filings

Schedules

Filings

Apr29

Earning Release(EST)

FY2026 Q1 Earning Release

Jan28

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 4.711 B, Net Income 480 M, EPS 0.4085

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Teva Pharmaceutical Industries(TEVA.US)

Teva Pharmaceutical Industries Stock Performance Chart

Trending